5 Stocks to Buy According to Neil Shahrestani’s Ikarian Capital

 2. Chimerix, Inc. (NASDAQ: CMRX)

Shahrestani’s Stake Value: $15,399,000
Percentage of Neil Shahrestani’s 13F Portfolio: 0.52%
Number of Hedge Fund Holders: 16

Chimerix, Inc. (NASDAQ: CMRX) is a biopharmaceutical company discovering, developing, and marketing medicines for patients with fatal diseases. The company was founded in 2000 and stands second on the list of 10 best stocks to buy according to Neil Shahrestani’s Ikarian Capital. Chimerix shares have gained a whopping 113.18% over the last 12 months.

On June 6, H.C. Wainwright analyst Edward White raised the price target on Chimerix, Inc. (NASDAQ: CMRX) to $19 from $18 and kept a “Buy” rating on the shares. On June 4, Chimerix announced that the United States FDA approved TEMBEXA tablets and oral suspension for Smallpox treatment. 

In the first quarter of 2021, 3G Capital increased its stake in Chimerix, Inc. (NASDAQ: CMRX) by 30% to 1.60 million shares. The company is also getting the attention of the smart money, as 16 hedge funds tracked by Insider Monkey reported owning stakes in the company in the first quarter of 2021, up from 13 funds a quarter earlier.